CrystalsFirst is a leading specialist in structure-based drug discovery and target enablement. Founded in 2018, CrystalsFirst has developed the MAGNET Discovery Engine, accelerating small molecule drug discovery by uniting patented high-throughput structural biology with AI-powered design. Using this unique “structure-first” approach, CrystalsFirst has successfully enabled structural data and hit finding for over 60 drug targets, empowering pharma and biotech partners to design novel modulators for proteins that were previously intractable.